America is Taking the Fight to Cancer

Bold new investments in the U.S. by biopharma companies are making more cancers beatable.

Biopharmaceutical companies across the U.S. are investing billions of dollars into developing and manufacturing breakthrough cancer treatments, transforming what is possible for patients.

From cutting-edge cell therapies and immunotherapies to next-generation radiopharmaceuticals, companies are developing new approaches designed to target some of the most difficult-to-treat cancers. At the same time, they are also expanding their domestic manufacturing footprint, generating high-quality jobs in local communities while also helping to ensure new cancer medicines are available first to U.S. patients.

By combining scientific innovation with domestic manufacturing and collaboration across the healthcare ecosystem, America’s biopharmaceutical industry is helping bring new hope to patients and families while shaping the future of cancer care.

Continued investment in research and development and advanced manufacturing is critical to ensuring the next generation of cancer breakthroughs reach patients in need.